Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angelo Maria Patti

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 11, 2018
Management of Statin Intolerance in 2018: Still More Questions Than AnswersPeter P Toth, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Cardiovascular Diabetology|February 25, 2014
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot studyManfredi Rizzo, Manisha Chandalia, Angelo Maria Patti, et al.
Giornale Italiano Di Cardiologia (2006)|April 20, 2016
[The extra-glycemic effects of liraglutide: focus on cardiometabolic markers]Rosaria Vincenza Giglio, Angelo Maria Patti, Dragana Nikolic, et al.
Angiology|June 21, 2013
Effects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot studyManfredi Rizzo, Rosaria Vincenza Giglio, Dragana Nikolic, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 21, 2018
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanismsManfredi Rizzo, Dragana Nikolic, Angelo Maria Patti, et al.
Current Pharmaceutical Design|February 1, 2018
Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular DiseasesRosaria Vincenza Giglio, Angelo Maria Patti, Arrigo F G Cicero, et al.
Biomolecules|January 21, 2023
Relationship among Body Composition, Adipocytokines, and Irisin on Exercise Capacity and Quality of Life in COPD: A Pilot StudyGiuseppina Cuttitta, Maria Ferraro, Fabio Cibella, et al.
Biomedicines|May 27, 2023
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 DiabetesAngelo Maria Patti, Rosaria Vincenza Giglio, Alberto Allotta, et al.
International Journal of Molecular Sciences|April 30, 2021
Novel Therapeutical Approaches to Managing Atherosclerotic RiskRosaria Vincenza Giglio, Anca Pantea Stoian, Khalid Al-Rasadi, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|December 30, 2024
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategiesVincenzo Rizza, Lara Tondi, Angelo Maria Patti, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|January 11, 2018
Management of Statin Intolerance in 2018: Still More Questions Than AnswersPeter P Toth, Angelo Maria Patti, Rosaria Vincenza Giglio, et al.
Cardiovascular Diabetology|February 25, 2014
Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot studyManfredi Rizzo, Manisha Chandalia, Angelo Maria Patti, et al.
Giornale Italiano Di Cardiologia (2006)|April 20, 2016
[The extra-glycemic effects of liraglutide: focus on cardiometabolic markers]Rosaria Vincenza Giglio, Angelo Maria Patti, Dragana Nikolic, et al.
Angiology|June 21, 2013
Effects of chitosan on plasma lipids and lipoproteins: a 4-month prospective pilot studyManfredi Rizzo, Rosaria Vincenza Giglio, Dragana Nikolic, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|May 21, 2018
GLP-1 receptor agonists and reduction of cardiometabolic risk: Potential underlying mechanismsManfredi Rizzo, Dragana Nikolic, Angelo Maria Patti, et al.
Current Pharmaceutical Design|February 1, 2018
Polyphenols: Potential Use in the Prevention and Treatment of Cardiovascular DiseasesRosaria Vincenza Giglio, Angelo Maria Patti, Arrigo F G Cicero, et al.
Biomolecules|January 21, 2023
Relationship among Body Composition, Adipocytokines, and Irisin on Exercise Capacity and Quality of Life in COPD: A Pilot StudyGiuseppina Cuttitta, Maria Ferraro, Fabio Cibella, et al.
Biomedicines|May 27, 2023
Effect of Semaglutide on Subclinical Atherosclerosis and Cardiometabolic Compensation: A Real-World Study in Patients with Type 2 DiabetesAngelo Maria Patti, Rosaria Vincenza Giglio, Alberto Allotta, et al.
International Journal of Molecular Sciences|April 30, 2021
Novel Therapeutical Approaches to Managing Atherosclerotic RiskRosaria Vincenza Giglio, Anca Pantea Stoian, Khalid Al-Rasadi, et al.
International Journal of Cardiology. Cardiovascular Risk and Prevention|December 30, 2024
Diabetic cardiomyopathy: pathophysiology, imaging assessment and therapeutical strategiesVincenzo Rizza, Lara Tondi, Angelo Maria Patti, et al.
Pageof 5